The rating assignment is based on a number of factors, including BayCare’s strong financial performance, excellent liquidity position and leading market position despite major competition in its primary service area.
These strengths are offset by challenges associated with BayCare’s growth strategy through recent acquisitions, as well as its endeavor to launch a health plan.
The outlook is stable, reflecting Moody’s Investors Service’s belief that BayCare’s financial performance will continue to mirror historical levels.
More articles on healthcare finance:
Canon makes $5.9B bid for Toshiba medical unit
7 thoughts on private equity in RCM
S&P revises Reid Health’s outlook to negative
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
